D. Artemov

发表

Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy.

Dmitri Artemov, Zaver M Bhujwalla, Z. Bhujwalla, 2010, ACS nano.

Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells

V. Raman, Z. Bhujwalla, Marie-France Penet, 2010, NMR in biomedicine.

Dynamic glucose enhanced (DGE) MRI for combined imaging of blood–brain barrier break down and increased blood volume in brain cancer

Jiadi Xu, Yoshinori Kato, Peter C M van Zijl, 2015, Magnetic resonance in medicine.

Natural D‐glucose as a biodegradable MRI contrast agent for detecting cancer

Yoshinori Kato, Dmitri Artemov, J. Bulte, 2012, Magnetic resonance in medicine.

Combined vascular and extracellular pH imaging of solid tumors

D Artemov, R. Gillies, M. Solaiyappan, 2002, NMR in biomedicine.

Conjugation of poly-L-lysine to bacterial cytosine deaminase improves the efficacy of enzyme/prodrug cancer therapy.

Z. Bhujwalla, Cong Li, Marie-France Penet, 2008, Journal of medicinal chemistry.

CHAPTER 45 – MRI for Molecular Imaging Applications: Overview, Perspectives, and Challenges

D. Artemov, 2009 .

MRI of regular‐shaped cell‐encapsulating polyhedral microcontainers

Barjor Gimi, David H Gracias, Dmitri Artemov, 2007, Magnetic resonance in medicine.

Advances in Monitoring Cell-Based Therapies with Magnetic Resonance Imaging: Future Perspectives

Dmitri Artemov, D. Artemov, Ethel J. Ngen, 2017, International journal of molecular sciences.

Imaging transplanted stem cells in real time using an MRI dual-contrast method

B. Krishnamachary, D. Artemov, K. Gabrielson, 2015, Scientific Reports.

Broadband proton decoupling for in vivo brain spectroscopy in humans

A. J. Shaka, X. Golay, Mari A. Smith, 2001, Magnetic resonance in medicine.

MR molecular imaging of the Her‐2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles

Dmitri Artemov, Noriko Mori, Zaver M Bhujwalla, 2003, Magnetic resonance in medicine.

Cellular Delivery of Bioorthogonal Pretargeting Therapeutics in PSMA-Positive Prostate Cancer.

Martin G Pomper, S. Lupold, D. Artemov, 2019, Molecular pharmaceutics.

Molecular and functional imaging of cancer: advances in MRI and MRS.

Barjor Gimi, Arvind P Pathak, Ellen Ackerstaff, 2004, Methods in enzymology.

Magnetic resonance imaging contrast of iron oxide nanoparticles developed for hyperthermia is dominated by iron content

R. Ivkov, M. Hedayati, T. DeWeese, 2014, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Advances in Brief Magnetic Resonance Molecular Imaging of the HER-2 / neu Receptor 1

Z. Bhujwalla, N. Mori, R. Ravi, 2003 .

Noninvasive detection of temozolomide in brain tumor xenografts by magnetic resonance spectroscopy.

D. Artemov, Y. Kato, B. Okollie, 2010, Neuro-oncology.

Optimization of SABRE for polarization of the tuberculosis drugs pyrazinamide and isoniazid

K. D. Atkinson, P. V. van Zijl, M. McMahon, 2013, Journal of magnetic resonance.

The Tumor Microenvironment in Nanoparticle Delivery and the Role of Imaging to Navigate Roadblocks and Pathways

Z. Bhujwalla, D. Artemov, 2016 .

Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis.

J. Geschwind, D. Lambert, D. Artemov, 2000, Journal of vascular and interventional radiology : JVIR.

Pharmacokinetics of the 13C labeled anticancer agent temozolomide detected in vivo by selective cross‐polarization transfer

J. Griffiths, R. Maxwell, Z. Bhujwalla, 1995, Magnetic resonance in medicine.

Direct Cell Labeling to Image Transplanted Stem Cells in Real Time Using a Dual-Contrast MRI Technique.

D. Artemov, Y. Kato, Ethel J. Ngen, 2017, Current protocols in stem cell biology.

Association between breast cancer, breast density, and body adiposity evaluated by MRI

K. Macura, D. Artemov, P. Huang, 2016, European Radiology.

Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis

L. Riley, F. Askin, J. Carrino, 2013, Nature Medicine.

Click Chemistry in the Development of Contrast Agents for Magnetic Resonance Imaging

D. Artemov, Sudath Hapuarachchige, S. Hapuarachchige, 2016, Topics in magnetic resonance imaging : TMRI.

Development of novel chimeric transmembrane proteins for multimodality imaging of cancer cells

V. Raman, P. Winnard, D. Artemov, 2007, Cancer biology & therapy.

Band-selective heteronuclear cross polarization in liquids.

Z. Bhujwalla, J. Glickson, D. Artemov, 1995, Journal of magnetic resonance. Series B.

Molecular MR Imaging of CD44 in Breast Cancer with Hyaluronan-Based Contrast Agents

D. Artemov, Wenlian Zhu, 2009 .

Contributing factors of temozolomide resistance in MCF-7 tumor xenograft models

F. Vesuna, V. Raman, Z. Bhujwalla, 2007, Cancer biology & therapy.

Functional and molecular magnetic resonance imaging of preclinical cancer models in drug discovery and development

A. Pathak, V. Raman, Z. Bhujwalla, 2006 .

Phospholipid profiles of invasive human breast cancer cells are altered towards a less invasive phospholipid profile by the anti-inflammatory agent indomethacin.

Z. Bhujwalla, N. Mori, E. Aboagye, 2000, Advances in enzyme regulation.

Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice

S. Sarkar, D. Artemov, M. Backer, 2015, Pharmaceutical Research.

Lymph node metastasis in breast cancer xenografts is associated with increased regions of extravascular drain, lymphatic vessel area, and invasive phenotype.

M. Neeman, A. Pathak, Z. Bhujwalla, 2006, Cancer research.

Noninvasive imaging identifies new roles for cyclooxygenase‐2 in choline and lipid metabolism of human breast cancer cells

Z. Bhujwalla, F. Wildes, D. Artemov, 2012, NMR in biomedicine.

Bioorthogonal two-component drug delivery in HER2(+) breast cancer mouse models

D. Artemov, Y. Kato, Sudath Hapuarachchige, 2014, Scientific Reports.

Twist contributes to hormone resistance in breast cancer by down-regulating estrogen receptor alpha

P. V. van Diest, F. Vesuna, V. Raman, 2011, Oncogene.

Image-Guided Enzyme/Prodrug Cancer Therapy

Z. Bhujwalla, Cong Li, Marie-France Penet, 2008, Clinical Cancer Research.

Ultrasmall Superparamagnetic Iron Oxide Nanoparticles as Nanocarriers for Magnetic Resonance Imaging: Development and In Vivo Characterization

D. Artemov, Sudath Hapuarachchige, Ge Si, 2022, ACS Applied Nano Materials.

Monitoring of release of cargo from nanocarriers by MRI/MR spectroscopy (MRS): Significance of T2/T 2* effect of iron particles

D. Artemov, Y. Kato, 2009, Magnetic resonance in medicine.

Synthesis and Evaluation of Gd(III) -Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate-Specific Membrane Antigen.

M. Pomper, T. Meade, Z. Bhujwalla, 2015, Angewandte Chemie.

Theranostics and metabolotheranostics for precision medicine in oncology.

Z. Bhujwalla, Jiefu Jin, Marie-France Penet, 2018, Journal of magnetic resonance.

Water exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy

D. Artemov, Y. Kato, Wenlian Zhu, 2014, Magnetic Resonance Materials in Physics, Biology and Medicine.

Targeted Agents for MRI

D. Artemov, 2008 .

Imaging of glucose uptake in breast tumors using non-labeled D-glucose

P. Zijl, Z. Bhujwalla, D. Artemov, 2010 .

Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470.

Meiyappan Solaiyappan, Dmitri Artemov, Zaver M Bhujwalla, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Dual-Modality PET-SPECT Image-Guided Pretargeting Delivery in HER2(+) Breast Cancer Models.

Wojciech G. Lesniak, D. Artemov, R. Mease, 2021, Biomacromolecules.

Theranostic Pretargeting Drug Delivery and Imaging Platforms in Cancer Precision Medicine

D. Artemov, Sudath Hapuarachchige, S. Hapuarachchige, 2020, Frontiers in Oncology.

PAMAM dendrimer‐based contrast agents for MR imaging of Her‐2/neu receptors by a three‐step pretargeting approach

Z. Bhujwalla, D. Artemov, Wenlian Zhu, 2008, Magnetic resonance in medicine.

Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.

D Artemov, M. Solaiyappan, Z. Bhujwalla, 2001, Neoplasia.

Anti-inflammatory agent indomethacin reduces invasion and alters metabolism in a human breast cancer cell line.

Barjor Gimi, Ellen Ackerstaff, Dmitri Artemov, 2007, Neoplasia.

Imaging prostate cancer invasion with multi-nuclear magnetic resonance methods: the Metabolic Boyden Chamber.

R. Gillies, Z. Bhujwalla, U. Pilatus, 2000, Neoplasia.

Noninvasive 1H/13C magnetic resonance spectroscopic imaging of the intratumoral distribution of temozolomide

Yoshinori Kato, Dmitri Artemov, D. Artemov, 2006, Magnetic resonance in medicine.

Magnetic resonance pharmacoangiography to detect and predict chemotherapy delivery to solid tumors.

D Artemov, M. Solaiyappan, Z. Bhujwalla, 2001, Cancer research.

Inhibition of TGF–β signaling in subchondral bone mesenchymal stem cells attenuates osteoarthritis

L. Riley, F. Askin, J. Carrino, 2013, Nature Medicine.

Localized hypoxia results in spatially heterogeneous metabolic signatures in breast tumor models.

R. Heeren, V. Raman, Z. Bhujwalla, 2012, Neoplasia.

Characterizing vascular parameters in hypoxic regions: a combined magnetic resonance and optical imaging study of a human prostate cancer model.

Arvind P Pathak, Dmitri Artemov, Venu Raman, 2006, Cancer research.

Noninvasive multiparametric imaging of metastasis-permissive microenvironments in a human prostate cancer xenograft.

Arvind P Pathak, Dmitri Artemov, Venu Raman, 2009, Cancer research.

Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.

G. Semenza, Z. Bhujwalla, L. Dillehay, 2000, Genes & development.

Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA

D Artemov, Z. Bhujwalla, D. Artemov, 2009, Cancer Gene Therapy.

PSMA-targeted theranostic nanoplex for prostate cancer therapy.

M. Pomper, Z. Bhujwalla, S. Banerjee, 2012, ACS nano.

Magnetic resonance molecular imaging of the HER-2/neu receptor.

Dmitri Artemov, Noriko Mori, Zaver M Bhujwalla, 2003, Cancer research.

Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer.

P. V. van Diest, A. Pathak, F. Vesuna, 2005, Cancer research.

Invasive Breast Cancer Preferably and Predominantly Occurs at the Interface Between Fibroglandular and Adipose Tissue

K. Macura, S. Harvey, D. Euhus, 2017, Clinical breast cancer.

Characterization of a major permeability barrier in the zebrafish embryo.

D Artemov, U. Pilatus, D. Artemov, 1998, Biology of reproduction.

THE MODERN VIEW ON THE PATHOGENESIS OF THE ISCHEMIA–REPERFUSION SYNDROME IN KIDNEY TRANSPLANTATION

D. Artemov, A. Zulkarnaev, 2018, Nephrology (Saint-Petersburg).

Dynamics of prostate cancer cell invasion studied in vitro by NMR microscopy

J. Nelson, Z. Bhujwalla, U. Pilatus, 1999, Magnetic resonance in medicine.

Controlled internalization of Her-2/neu receptors by cross-linking for targeted delivery

D. Artemov, Wenlian Zhu, B. Okollie, 2007, Cancer biology & therapy.

Metabolic signatures imaged in cancer-induced cachexia.

B. Krishnamachary, M. Pomper, Z. Bhujwalla, 2011, Cancer research.

MRI and MRS of intact perfused cancer cell metabolism, invasion, and stromal cell interactions

B. Krishnamachary, Z. Bhujwalla, S. Bharti, 2019, NMR in biomedicine.

Intratumoral conversion of 5-fluorocytosine to 5-fluorouracil by monoclonal antibody-cytosine deaminase conjugates: noninvasive detection of prodrug activation by magnetic resonance spectroscopy and spectroscopic imaging.

D Artemov, Z. Bhujwalla, E. Aboagye, 1998, Cancer research.

Magnetic resonance imaging and spectroscopy of transgenic models of cancer

A. Pathak, V. Raman, Z. Bhujwalla, 2007, NMR in biomedicine.

Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression.

Z. Bhujwalla, N. Mori, D. Artemov, 2002, Neoplasia.

'The metabolism of tumours': 70 years later.

G. Semenza, D. Feldser, P. Taghavi, 2001, Novartis Foundation symposium.

Molecular and functional imaging of breast cancer

M A Jacobs, A P Pathak, D Artemov, 2009, NMR in biomedicine.

Molecular Imaging of Cancer: Applications of Magnetic Resonance Methods

Barjor Gimi, Zaver M. Bhujwalla, Arvind P. Pathak, 2005, Proceedings of the IEEE.

Real‐time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti‐inflammatory agent indomethacin

Ellen Ackerstaff, Kristine Glunde, Dmitri Artemov, 2002, Magnetic resonance in medicine.

Heterogeneity of Tumor Vasculature and Antiangiogenic Intervention: Insights from MR Angiography and DCE-MRI

D. Artemov, Y. Kato, Wenlian Zhu, 2014, PloS one.

Magnetic resonance imaging of cell surface receptors using targeted contrast agents.

J. Bulte, Z. Bhujwalla, D. Artemov, 2004, Current pharmaceutical biotechnology.

Cancer insights from magnetic resonance spectroscopy of cells and excised tumors

Raj Kumar Sharma, Z. Bhujwalla, N. Mori, 2022, NMR in biomedicine.

Characterizing extravascular fluid transport of macromolecules in the tumor interstitium by magnetic resonance imaging.

Michal Neeman, Arvind P Pathak, Dmitri Artemov, 2005, Cancer research.

Metabolic Imaging of Pancreatic Ductal Adenocarcinoma Detects Altered Choline Metabolism

B. Krishnamachary, A. Maitra, Z. Bhujwalla, 2014, Clinical Cancer Research.

Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model.

F. Vesuna, V. Raman, Z. Bhujwalla, 2008, Cancer research.

Choline Phospholipid Metabolites of Human Vascular Endothelial Cells Altered by Cyclooxygenase Inhibition, Growth Factor Depletion, and Paracrine Factors Secreted by Cancer Cells

Z. Bhujwalla, N. Mori, D. Artemov, 2003 .

Molecular magnetic resonance imaging with targeted contrast agents

Dmitri Artemov, D. Artemov, 2003, Journal of cellular biochemistry.

The effect of the mTOR inhibitor rapamycin on glucoCEST signal in a preclinical model of glioblastoma

P. V. van Zijl, Linda Knutsson, J. Laterra, 2019, Magnetic resonance in medicine.

Magnetic Resonance Guided Navigation of Untethered Microgrippers

David H Gracias, Dmitri Artemov, Arijit Ghosh, 2020, Advanced healthcare materials.

0595 TITLE : Prostate-Specific Membrane Antigen ( PSMA ) Targeted Bio-orthogonal Therapy for Metastatic Prostate Cancer

Principal Investigator, D. Artemov, 2018 .

Lymphatic endothelial cells actively regulate prostate cancer cell invasion

Z. Bhujwalla, F. Wildes, D. Artemov, 2016, NMR in biomedicine.

Choline phospholipid metabolites of human vascular endothelial cells altered by cyclooxygenase inhibition, growth factor depletion, and paracrine factors secreted by cancer cells.

Z. Bhujwalla, N. Mori, D. Artemov, 2003, Molecular imaging.

Combined MR, fluorescence and histology imaging strategy in a human breast tumor xenograft model

Kristine Glunde, Dmitri Artemov, Venu Raman, 2013, NMR in biomedicine.

Integrated Systems and Technologies Metabolic Signatures Imaged in Cancer-Induced Cachexia

B. Krishnamachary, M. Pomper, Z. Bhujwalla, 2011 .

The physiological environment in cancer vascularization, invasion and metastasis.

R. Gillies, M. Solaiyappan, Z. Bhujwalla, 2001, Novartis Foundation symposium.

Cell Viability and Noninvasive In Vivo MRI Tracking of 3D Cell Encapsulating Self-Assembled Microcontainers

Barjor Gimi, Matthias Stuber, David H Gracias, 2007, Cell transplantation.

Self-Assembled Three Dimensional Radio Frequency (RF) Shielded Containers for Cell Encapsulation

Barjor Gimi, David H. Gracias, Zhiyong Gu, 2005, Biomedical microdevices.

A preclinical murine model for the early detection of radiation-induced brain injury using magnetic resonance imaging and behavioral tests for learning and memory: with applications for the evaluation of possible stem cell imaging agents and therapies

D. Artemov, K. Gabrielson, Y. Kato, 2016, Journal of Neuro-Oncology.

HIF isoforms have divergent effects on invasion, metastasis, metabolism and formation of lipid droplets

B. Krishnamachary, Z. Bhujwalla, F. Wildes, 2015, Oncotarget.

Intracellular volume and apparent diffusion constants of perfused cancer cell cultures, as measured by NMR

D Artemov, P. V. van Zijl, U. Pilatus, 1997, Magnetic resonance in medicine.

Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice

S. Sarkar, D. Artemov, M. Backer, 2015, Pharmaceutical Research.

Noninvasive visualization of in vivo release and intratumoral distribution of surrogate MR contrast agent using the dual MR contrast technique.

I. Jacobs, Y. Onuki, D. Artemov, 2010, Biomaterials.

Novel Imaging Agents for Molecular MR Imaging of Cancer

Z. Bhujwalla, D. Artemov, 2010 .

Hypoxia and the presence of human vascular endothelial cells affect prostate cancer cell invasion and metabolism.

R. Gillies, Z. Bhujwalla, D. Artemov, 2007, Neoplasia.

Bioorthogonal, two-component delivery systems based on antibody and drug-loaded nanocarriers for enhanced internalization of nanotherapeutics.

Yoshinori Kato, Dmitri Artemov, D. Artemov, 2014, Biomaterials.

MR – eyes for cancer: looking within an impenetrable disease

Z. Bhujwalla, K. Farahani, Marie-France Penet, 2013, NMR in biomedicine.

Receptor imaging of pediatric tumors: clinical practice and new developments

R. Hawkins, H. Daldrup-Link, R. Goldsby, 2008, Pediatric Radiology.

Non-Temperature Induced Effects of Magnetized Iron Oxide Nanoparticles in Alternating Magnetic Field in Cancer Cells

D. Artemov, Michael. Delannoy, Y. Kato, 2016, PloS one.

Development of 5D3-DM1: A Novel Anti-Prostate-Specific Membrane Antigen Antibody-Drug Conjugate for PSMA-Positive Prostate Cancer Therapy.

V. Raman, D. Artemov, C. Bařinka, 2020, Molecular pharmaceutics.

Tumor angiogenesis, vascularization, and contrast-enhanced magnetic resonance imaging.

D Artemov, J. Glockner, Z. Bhujwalla, 1999, Topics in magnetic resonance imaging : TMRI.

In Vivo Selective Measurement of {1−13C}‐Glucose Metabolism in Tumors by Heteronuclear Cross Polarization

D Artemov, Z. Bhujwalla, J. Glickson, 1995, Magnetic resonance in medicine.

Two‐compartment model for determination of glycolytic rates of solid tumors by in vivo 13C NMR spectroscopy

D Artemov, Z. Bhujwalla, U. Pilatus, 1998, NMR in biomedicine.

Diffusion-weighted and macromolecular contrast enhanced MRI of tumor response to antivascular therapy with ZD6126

Barjor Gimi, Dmitri Artemov, Zaver M Bhujwalla, 2007, Cancer biology & therapy.

Real‐time measurements of cellular oxygen consumption, pH, and energy metabolism using nuclear magnetic resonance spectroscopy

Z. Bhujwalla, U. Pilatus, N. Mori, 2001, Magnetic resonance in medicine.

Biocompatible blood pool MRI contrast agents based on hyaluronan.

D. Artemov, Wenlian Zhu, 2011, Contrast media & molecular imaging.

Development of 5D3 mAb and USPIO-Based Theranostics for Image-Guided Prostate Cancer Therapy

R. Morgan, D. Artemov, X. Xxxx, 2022 .

Noninvasive imaging identifies new roles for cyclooxygenase‐2 in choline and lipid metabolism of human breast cancer cells

Z. Bhujwalla, F. Wildes, D. Artemov, 2012, NMR in biomedicine.

MR / OPTICAL IMAGE-GUIDED TWO-COMPONENT NANO-DELIVERY SYSTEMS TARGETING HER 2 / NEU OVEREXPRESSING CANCER CELLS

D. Artemov, Y. Kato, Wenlian Zhu, 2011 .

Prostate fibroblasts and prostate cancer associated fibroblasts exhibit different metabolic, matrix degradation and PD-L1 expression responses to hypoxia

Raj Kumar Sharma, B. Krishnamachary, Z. Bhujwalla, 2024, Frontiers in Molecular Biosciences.